Eric Hodgins Leads Tech Innovation at Precision Medicine Group
In an impressive move for the world of pharma services, Eric Hodgins has stepped into the role of Chief Information and Technology Officer at Precision Medicine Group (PMG). With his 30-year track record of building award-winning clinical and commercial technologies, Hodgins is poised to elevate PMG’s advancements in R&D and commercial services, charging into the future armed with transformative technology strategies.
Driving Transformation at PMG
Eric Hodgins will bring a wealth of expertise to PMG. Known for his strategic foresight and dedication to advancing patient care, he’ll be sculpting the technological landscape of PMG’s clinical and commercial services. Hodgins will direct Precision’s technology assets and strategies, ensuring seamless integration for a more streamlined operation. “Eric is a visionary,” says Margaret Keegan, CEO of PMG, highlighting Hodgins’ ability to deliver transformative results and raise the bar for biopharma companies.
A Legacy of Innovation
Before PMG, Hodgins was a Senior Vice President at IQVIA, where he honed technology offerings to improve clinical trial efficiency and patient engagement. His newly forged path at PMG will leverage these skills to tailor innovative technologies that meet the specific needs of clients, enhancing PMG’s R&D and commercialization efforts.
The Growing Role of IT in Pharma
Information technology’s role in drug development is only intensifying, with AI and other emerging tech providing real-time, actionable insights for biopharmaceuticals. Hodgins’ perspective echoes the importance of aligning technology with agility, quality, and efficiency—key attributes for success in the competitive pharma landscape.
Who is Eric Hodgins?
Hodgins’ career began as a founder and Chief Technology Officer of a clinical tech startup, a venture which laid the foundation for a compelling journey in tech innovation. His capacity to align business and technology strategy positions him uniquely to support PMG’s next-gen approaches to drug development.
According to PR Newswire, PMG continues to lead the industry in innovative approaches. With Hodgins at the helm of their technology, the prospect for trailblazing advancements seems more promising than ever.
For more information about Precision Medicine Group and their pioneering work, visit their website at precisionmedicinegrp.com.
